Sequence- and Structure-Dependent Cytotoxicity of Phosphorothioate and 2′-O-Methyl Modified Single-Stranded Oligonucleotides

August 22nd, 2024|Categories: Perspectives on Current Science|

Authors: Laura V. Croft  Mark Fisher, Tabassum Khair Barbhuiya, Serene El-Kamand, Samuel Beard, Aleksandra Rajapakse, Roland Gamsjaeger, Liza Cubeddu, Emma Bolderson, Ken O’Byrne , Derek Richard derek.richard@qut.edu.au, and Neha S. Gandhi Published Online: 17 June 2024 Abstract Single-stranded oligonucleotides (SSOs) are a rapidly expanding class ...

Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation

August 22nd, 2024|Categories: Perspectives on Current Science|

Authors: Jillian Belgrad, Hassan H. Fakih, and Anastasia Khvorova Published Online: 3 April 2024 Abstract Nucleic acid-based therapies have become the third major drug class after small molecules and antibodies. The role of nucleic acid-based therapies has been strengthened by recent regulatory approvals and ...

ALS: From Genetic Complexity to Treatment Challenges and Advances

August 6th, 2024|Categories: Perspectives on Current Science|

Amyotrophic Lateral Sclerosis (ALS), commonly called Lou Gehrig's disease, is a neurodegenerative disorder of the motor neurons that causes progressive muscle weakness and respiratory failure (1). ALS is the most common motor disease among adults (2), affecting around 60,000 people in the U.S. and ...

Inherited Retinal Disorder: In Vivo CRISPR Therapy Provides Vision Improvements

July 16th, 2024|Categories: Perspectives on Current Science|

Inherited retinal disorders (IRDs) are the leading cause of visual impairment, affecting approximately 1 in 2,000 people of all ages worldwide (1). There are many types of IRDs, each caused by a gene variant that affects how the retina functions, with one of the ...

Hope of New Treatments for Chronic Liver Disease MASH (NASH)

May 7th, 2024|Categories: Perspectives on Current Science|

In the early stages of Metabolic Dysfunction-Associated Steatohepatitis (MASH), many patients are asymptomatic, though some may feel weak or fatigued or have an ache in their upper right abdomen. While lifestyle changes can help patients diagnosed early enough, more advanced stages of the disease ...

RNA Single-base Editing Therapy that Treats Genetic Lung and Liver Disease Entered Clinical Trials

April 16th, 2024|Categories: Perspectives on Current Science|

When Peggy's mom was in her forties, she started to have trouble breathing. Although she had never smoked, she had been exposed second-hand earlier in her life. Eventually, her mother ended up at the Mayo Clinic, where she was the 36th patient to be ...

FDA Approved the First CRISPR Treatment – Potential Cure for People with Sickle Cell Disease

March 14th, 2024|Categories: Perspectives on Current Science|

Victoria Gray was diagnosed with sickle cell disease (SCD) when she was just three months old; since then, episodes of pain and frequent hospitalizations have been a part of her life. Many of her dreams seemed like far-off impossibilities when the smallest things, like ...

Go to Top